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ABSTRACT. The aim of this study was to investigate the effects of anaesthetic combinations of xylazine, detomidine, 
sevoflurane and isoflurane on clinical, laboratory, and cardiovascular parameters as well as their effects on intraocular pres-
sure in horses. Twenty-four mixed-breed horses (twelve male and twelve female) were used for this study. The horses were 
allocated into four groups (six horses in each group): XS (xylazine-sevoflurane), XI (xylazine-isoflurane), DS (detomi-
dine-sevoflurane) and DI (detomidine-isoflurane). Clinical evaluations, hematological, biochemical tests and measurement 
of intraocular pressure were done before (0th), during (5th, 15th and 30th min) and at the end of anaesthesia (60th min). 
The detected differences were statistically evaluated. In conclusion, this study shows that the anaesthetic combinations of 
sevoflurane and isoflurane with xylazine and detomidine provided safe and suitable anaesthesia in horses. Our study did 
not reveal any statistical differences in intraocular pressure measurements. However, it should be noted that intraocular 
pressures were measured with the animals lying down and our results do not rule out changes in intraocular pressures in a 
standing position. We concluded that these anaesthesia protocols are suitable for ophthalmic surgery.
Keywords:  anaesthesia, equine, eye. 
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INTRODUCTION
Αlpha-2 (α-2) agonists are the greatest improvements in modern equine practice. 
For treatments and diagnostic procedures, α-2 
agonists are widely used in equine medicine and 
anaesthesia (Mutoh et al., 1997; Guedes et al., 
2017). Administration of α-2 agonists also reduces 
the amount of inhalational anaesthetic needed to 
maintain general anaesthesia in horses (Nyman et al., 
2009; Rohrbach et al., 2009). α-2 Agonists such as 
detomidine, xylazine, medetomidine and romifidine 
are used for premedication in horses, and they have 
similar properties (Arıcan et al., 2015).
 The inhalation anaesthetic agents such as isoflurane 
and sevoflurane are used for procedures requiring 
long-term anaesthesia in horses. Unlike injectable 
anesthetics, they enter the body through the lungs and 
move into systemic circulation from the respiratory 
tract (Hall et al., 2000; Del Barrio et al., 2017).
 Isoflurane is an inhalant anesthetic agent with a low 
blood/gas solubility (1.4 in horses) coefficient. The 
lower blood/gas solubility causes rapid induction 
and short recovery time from general anaesthesia 
(Kalchofner et al., 2009; Ida et al., 2013). It leads to 
dose-dependent cardiac and respiratory depression. 
The α-adrenergic stimulation associated with 
isoflurane increases blood flow in skeletal muscles 
and reduces systemic vascular resistance and arterial 
blood pressure (Yamashita et al., 2006; Steffey, 
2009). Sevoflurane is structurally similar to isoflurane 
but has lower blood/gas solubility (0.6 in horses). Its 
effects on the central nervous system (CNS) are fewer 
than those of isoflurane, but there is still a dose-
dependent depression. CNS depression is greater 
at increasing doses when compared to the other 
inhalation agents. It also reduces cerebral vascular 
resistance and metabolism at high doses (Yamanaka 
et al., 2001; Kronen, 2003). 
 Intraocular pressure (IOP) is defined as the equilibrium 
between production and drainage of humor aqueous 
in the ciliary processes of the eye. The anaesthetic 
agents may cause changes in IOP (Komáromy et al., 
2006; Monk et al., 2017). The aim of this study was 
to investigate the effects of xylazine, detomidine, 
isoflurane and sevoflurane anesthetic combinations on 
clinical, laboratory, and cardiovascular parameters as 
well as their effects on IOP in horses. 
MAŚLANKA T., ZUŚKA-PROT M.
MATERIALS AND METHODS 
 The current study was performed in the Surgery 
Department of the Faculty of Veterinary Medicine, 
University of Selcuk, Turkey and was approved by 
the Ethics Committee of the Faculty of Veterinary 
Medicine. Twenty-four mixed-breed horses (twelve 
male and twelve female) weighing 450 ± 51 kg, 7.6 
± 5 years old were used for this study. The clinical 
examination and hematological tests were done 
before starting the study. The horses were allocated 
into four groups (six horses in each group): XS 
(xylazine-sevoflurane), XI (xylazine-isoflurane), 
DS (detomidine-sevoflurane) and DI (detomidine-
isoflurane). All horses were fasted for 12 h before 
premedication; water intake was not restricted. 
Before premedication, the body weight, respiratory 
rate, body temperature, and heart rate of the horses 
were recorded.
 Before premedication, a 20-gauge intravenous 
catheter was placed in the right jugular vein for blood 
sample collection and administration of anaesthetic 
drugs. Electrocardiography (ECG) leads (aVL, aVR, 
aVF) and oxyhaemoglobin saturation (SpO2) were 
monitored by a BM3 Vet monitor (Bionet, Seoul, 
Korea) before premedication and during anaesthesia. 
Intravenous xylazine (1.1 mg/kg b.w., Rompun 
2%, Bayer, Mississauga, Canada) was used for 
premedication in XS and XI groups, and intravenous 
detomidine (6 µg/kg b.w., Domosedan, Pfizer, New 
York, NY, USA) was used for premedication in DS 
and DI groups. Ketamine hydrochloride (2 mg/kg 
b.w., Ketasol 10%, Richterpharma, Wels, Austria) and 
midazolam (0.03 mg/kg b.w., Demizolam, Curamed 
Pharma GmbH. Karlsruhe Germany) were mixed in 
the same syringe and intravenously administered to 
induce anesthesia for assisted fall. After induction 
of anaesthesia, horses were placed in left lateral 
recumbency and the trachea was intubated with a 
cuffed endotracheal tube with an internal diameter of 
30 mm. The endotracheal tube was attached to a large 
animal circle breathing system anaesthesia machine 
(Large animal LSD 3000 anaesthetic machine, 
Dublin, OH, USA, 12 breath/min), and anaesthesia 
was maintained with either sevoflurane (Sevorane 
liquid, Abbott Laboratories, Abbott Park, IL, USA) 
or isoflurane (Aerrane, Baxter Healthcare, Deerfield, 
IL,USA) for 60 min. The initial concentration of 
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sevoflurane was 8% + 4 l O
2
/min and was reduced 
to 4%. After 30 min of anaesthesia, the sevoflurane 
dose was changed to 2% + 4 l O
2
/min, which was 
maintained until the end of anaesthesia (60 min). 
The initial dosage of isoflurane was 5% + 4 l O
2
/min, 
which was reduced to 4% after 15 min. At 30 min of 
anaesthesia, the isoflurane dose was changed to 2.5 % 
+ 4 l O
2
/min, which was maintained until the end of 
anaesthesia (60 min). After 60 min, the administration 
of inhalation anaesthetics was discontinued, and all 
animals were supported with O
2
 for 10 min.
Clinical evaluations
Before pre-anaesthetic administration and during 
anesthesia (5th, 15th, 30th and 60th min) heart 
rate (HR), ECG, body temperature (BT), SPO
2
, 
respiratory rate (RR), systolic, diastolic and mean 
arterial pressure were measured and recorded. 
After initiation of inhalation anaesthesia, palpebral 
reflex was controlled during and at the end of 
anesthesia in all groups. Palpebral reflex (sluggish) 
time (PRs), corneal reflex (strong) (PRS), palpebral 
reflex (normal) (PRn), spontaneous respiration return 
time (SRRT) and standing up time (SUT) were 
recorded on examination papers.
Haematologic evaluations
Before (control) and during anaesthesia (5th, 15th, 
30th and 60th min) a 15-ml blood sample was 
collected from the right jugular vein for hematologic, 
blood gas, and biochemical evaluations.  Red blood 
count (RBC), white blood count (WBC), blood pH, 
venous partial carbon dioxide pressure (PvCO
2
), 
venous partial oxygen pressure (PvO
2
), total carbon 
dioxide (tCO
2
), hemoglobin level (Hb), hematocrit 
(Ht), bicarbonate (HCO
3
-), electrolytes (Na+, K+) and 
lactic acid were measured using a Gem Premier 3000 
(Biomerieux Diagnostics, Marcy l’Etoile, France) and 
a Medonic CA 530 hematology analyzer (PZ Cormay, 
Łomianki, Poland). 
Biochemical evaluations
The serum levels of total protein (TP), aspartate 
transaminase (AST), alanine transaminase (ALT), 
alkaline phosphatase (ALP), α-glutamyl transferase 
(γGT), total bilirubin (T-bil) and glucose (Glu) were 
measured before and at the end of anaesthesia (60th 
min) using a VetTest 8008 biochemical analyzer 
(Idexx Laboratories, Westbrook, ME, USA). 
Intraocular pressures measurements
Before pre-anaesthetic administration, eyes 
examination (palpebral, corneal and pupillary 
reflexes, conjunctiva) were done in all horses 
and intraocular pressures were measured using a 
TonoVet tonometer (Icare, Vantaa, Finland) before 
administering xylazine and detomidine (control) and 
at the 5th, 15th, 30th, and 60th min after inducing 
anaesthesia. The same eyes (right) were evaluated in 
all horses.
Data and statistical analysis
IBM SPSS 21 statistics programs were used to analyze 
the data. The Shapiro-Wilk test was used for normality 
then the one and two-way repeated measure (ANOVA) 
followed Tukey significance tests to compare intra-
group and inter-group values. The level of statistical 
significance was set at P ˂ 0.05. Results were 
presented as Mean ± SE (Standard Error).
RESULTS
Clinical evaluation results
In the current study, suitable and adequate sedation 
was provided in all groups. The clinical evaluations 
are shown in Table 1. There were significant 
differences seen in PRsT and SUT values between 
groups.  The PRsT values of sevoflurane groups were 
shorter than those of the isoflurane groups (P < 0.05). 
The SUT values were higher in group DS than in the 
others (P < 0.05). 
The cardiopulmonary findings are shown in Table 
2. Increases and decreases were seen in HR, SpO
2
 
Table 1. Clinical Evaluation of groups (Mean ± SE) PRsT; 
Palpebral reflex sluggish time, PRST; palpebral reflex 
strong time, SRRT; spontaneous respiration return time, 
SUT; standing up time, a,b,c; P ˂ 0,05 between groups.
Group      PRsT          PRST SRRT SUT
XS 5.98±0.57a 14.28±3.31 10.42±4.47 39.83±8.63a
XI 17.66±2.61b 14.54±0.80 18.55±1.21 32.00±4.41a
DS 5.80±0.71a,c 17.23±1.05 9.81±3.83 79.50±14.39b
DI 18.00±4.06b 14.50±3.13 23.66±6.29 26.83±1.72a
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and SP (systolic pressure) values before and during 
anaesthesia in all groups. The changes detected 
in these values were not statistically significant. 
Respiratory rate (RR) increased at 5 min and 
decreased from 15 min until the end of anaesthesia 
Table 2. Cardiopulmonary evaluation of groups (M±SE)
in XI (P < 0.05). Significant differences were seen 
in diastolic (DP) and mean pressures (MP) between 
and within groups (P < 0.05). Decreases of DP were 
recorded at 5th, 15th, 30th, 60th min of anaesthesia in 
XI, DS and DI. Increases of DP were detected at 15, 
Values
Groups 0th 5 th 15th 30th 60th
Reference 
ranges
HR
XS 57±8.42 47.6±12.04 62.8±13.33 52.1±10.99 51.3±9.24 28-45
XI 54±8.42 68±12.04 55.8±13.33 55±10.09 55.5±9.24 28-45
DS 46.8±8.42 51.6±12.04 56±13.33 34.8±10.99 31.8±9.24 28-45
DI 34.3±8.42 35.6±12.04 49.8±13.33 60.5±10.99 54.3±9.24 28-45
SpO
2
 %
XS 92.3±1.77 95.5±0.77 96.5±0.62 95.3±1.30 95±1.34 85-100
XI 95.6±1.37 97.8±0.77 97.1±0.62 94.6±1.30 94.6±1.34 85-100
DS 96.5±1.77 96.5±0.77 96.1±0.62 95.1±1.30 94.1±1.38 85-100
DI 94.3±1.77 96±0.77 96.5±0.62 95.5±1.30 96±1.34 85-100
RR
XS 15.5±4.01 16.6±4.54 19.4±5.74 14.4±3.17 11.4±1.43 8-20
XI 13.1±2.61ab 27.3±9.38a 11.6±2.04ab 7.2±1.20b 7.6±0.98b 8-20
DS 13.1±2.92 9±1.26 10.8±1.55 11.5±1.38 12.8±2.70 8-20
DI 10.4±2.56 8.75±2.78 13.5±4.99 18±7.18 7.6±1.60 8-20
BT
XS 36.8±0.09a 36.7±0.08a 35.9±0.12b 35.7±0.18b 35.7±0.2b 37.5-38
XI 37.1±0.21 37±0.22 36.5±0.42 36.3±0.41 36.1±0.30 37.5-38
DS 37±0.26 36.6±0.31 36.5±0.46 36.5±0.40 36.3±0.37 37.5-38
DI 37.1±0.34 36.8±0.34 37.1±0.27 36.9±0.35 36.9±0.40 37.5-38
SP
XS 153.3±7.81 105.3±5.57 151.5±10.14 107.8±10.17 87.8±6.22 112±14
XI 161.8±7.8 158.5±5.57 125.6±10.14 118.3±10.17 103.3±6.22 112±14
DS 153.6±7.81 153.6±5.57 122.5±10.14 118.3±10.17 103.3±6.22 112±14
DI 160.1±7.81 155.5±5.57 122.8±10.14 106.6±10.17 94.6±6.22 112±14
DP
XS 59.6±10.64*,a 58.3±8.57*,a 121.6±7.3*,b 104.1±5.82*,b 70.8±7.50a 70±14
XI 117±10.64a 107±8.57*,a 80.3±7.36a 61.5±5.82b 47±7.50b 70±14
DS 119.3±10.64a 83±8.57*,b,c 80.3±7.36a,c 61.5±5.82b,c 56.6±7.50b,c 70±14
DI 124.1±10.64a 95.5±8.57*,b 80.3±7.36b 61.5±5.82b 60.6±7.50b 70±14
MP
XS 99.5±19.86 77±12.5 132.8±8.14 106.1±6.57* 80.3±4.31 90±14
XI 109.4±21.76a,c 114.4±13.73a 97.2±8.92a 74.6±7.20b,c 68.6±4.72b,c 90±14
DS 98.6±19.86a 111.5±12.54a 91.6±8.14a 72.8±6.57b 67.1±4.31b 90±14
DI 96±19.80a 111.5±12.50a 91.6±8.12a 72.8±6.55b 67.1±4.28b 90±14
HR; heart rate, SpO
2
; oxygen saturation, RR; respiratory rate, BT; body temperature, SP; systolic pressure, DP; dia-
stolic pressure, MP; mean pressure, *,**; P ˂ 0.05 between groups evaluation, a,b,c ; P  ˂ 0.05 in groups evaluations. 
References: Arıcan et al. 2015.
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30, 60 min of anaesthesia in XS. In XI, DS and DI the 
MP increased at 5 min of anaesthesia and decreased 
until the end of anesthesia. In XS the MP decreased 
at 5 min and increased at 30 min of anaesthesia. BT 
decreased from 15 min until the end of anaesthesia in 
XS. The decrease of BT was statistically significant 
(P < 0.05). 
Haematologic results
The measured hematologic and blood gas parameters 
are shown in Table 3. In hematologic evaluations, 
RBC, WBC, Hb, Ht and lactic acid values showed 
changes. The changes of RBC, WBC, Hb and Ht 
values were in reference intervals in all groups. The 
lactic acid levels were lower than reference range 
before and during anaesthesia in all groups. In DS, 
there was significant difference recorded in lactic acid 
levels between 0th min and the other times. 
The pH values decreased at 15th min of anaesthesia 
in DS.  This reduction was below the reference 
range and it was significant (P < 0.05) (Table 3). 
At 0th, 5th, 15th, 30th, 60th min of anaesthesia, the 
PvCO
2
 values were higher in sevoflurane groups 
(XS and DS) than in isoflurane groups (XI and DI). 
The PvCO
2
 values increased during anaesthesia in 
sevoflurane groups. After 5 min of anaesthesia, the 
PvCO
2
 values started to decrease in isoflurane groups, 
and the reductions were significantly different (P < 
0.05). There were no significant differences seen in 
PvO
2
 values between groups at the 0th, 5th, 15th, 
30th and 60th min of anaesthesia. Before and during 
anaesthesia the PvO
2
 values were lower than reference 
range in DI (P < 0.05) (Table 3). Differences in tCO
2
 
values were seen in all groups. The tCO
2
 values were 
higher than reference range at 15th, 30th and 60th min 
of anaesthesia in XS and DS (P < 0.05). The other 
differences were in reference interval (Table 3). The 
HCO
3
 levels of XS and DS were significantly different 
from XI and DI (P < 0.05).
Biochemical results
Biochemical parameters are shown in Table 4.  There 
were significant differences detected in TP, AST, ALT 
and ALP values among and within groups. All of the 
values were within the normal range (Table 4). T-bil 
values were higher at 0 and 60th min of anesthesia 
than the reference range in XS.  At the end of the 
anaesthesia Glu values in XS, XI and DI were higher 
than XS and reference values (Table 4).
Intraocular pressures results
Intraocular pressures (IOP) were measured before 
and during anesthesia (5th, 15th, 30th and 60th min) 
(Table 5). There were no significant differences 
observed between and within groups (reference 
range: 13-37 mmHg).
DISCUSSION
Arıcan et al. (2015) compared the clinical effects 
of sevoflurane, isoflurane, and medetomidine 
anaesthetic combinations in horses. They found the 
loss of palpebral reflex, return of palpebral reflex 
and standing up times to be shorter in a sevoflurane 
group than in an isoflurane group. They attribute 
this to the low blood concentration of sevoflurane 
at a plane of anaesthesia and its relatively rapid 
elimination from the body. In our study, there were 
significant differences observed in PRsT and SUT (P 
< 0.05). Palpebral reflex sluggish time of sevoflurane 
groups was shorter than those of isoflurane groups 
which may be supported by the previous finding of 
low blood concentration and rapid elimination of 
sevoflurane from the blood. Detomidine binds α-2 
adrenoreceptors in the locus coeruleus and medulla 
spinalis to provide sedative and analgesic effects. 
It suppresses norepinephrine and dopamine release 
in CNS. Because of this, detomidine is more potent 
and has fewer side effects than xylazine. It has been 
reported that detomidine produces deeper and longer 
sedation than xylazine (Steffey and Pascoe, 2002; 
Rochbrach et al., 2009). In this study, SUT was 
longer in XS and DS than XI and DI. The longest 
and shortest times were detected in DS and DI. This 
condition suggested that anaesthetic combinations, 
anaesthetic doses and animal related factors (age, 
sex and weight) could influence the post anaesthetic 
parameters.  
Generally cardiac arrhythmias which occur during 
anaesthesia can cause serious problems, and 
Table 3. Hematological evaluation of groups (Mean ± SE).
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Values Groups 0th  5th 15th 30th 60th Reference ranges
RBC (x106/mm3)
XS 9.8±0.12 8.8±0.63 8.6±0.81 7.7±0.53 7.9±0.48 7-13
XI 10.3±0.43 8.1  ±0.34 7.5±0.28 7.3±0.33 7±0.19 7-13
DS 10.6±0.38 10.8±0.28 10.7±0.18 10.1±0.32 9.3±0.37 7-13
DI 9.7±1.07 10.9±0.87 11.4±0.48 11±0.32 10.6±0.43 7-13
WBC (x103/mm3)
XS 9±1.06 8.34±0.93 7.64±0.84 8±1.01 6.96±0.75 6-12.5
XI 10.6±0.74 9.4±0.63 9.2±0.59 8.6±0.66 8.3±0.63 6-12.5
DS 7.8±0.42 8.9±1.23 8.6±1.42 8.65±0.95 7,6±0.60 6.12.5
DI 8±1.20 9.1±1.26 9.2±1.07 9.6±0.95 9.5±0.95 6-12.5
pH
XS 7.3±0.02 7.3±0.02 7.3±0.02 7.3±0.02 7.3±0.02 7.36-7.43
XI 7.4±0.001 7.3±0,001 7.4±0.01* 7.4±0.08 7.4±0.03 7.36-7.43
DS 7.4±0.001a 7.3±0.02ab 7.2±0.02*,b 7.2±0.02b 7.2±0.02b 7.36-7.43
DI 7.4±0.01 7.3±0.02 7.3±0.01 7.4±0.03 7.4±0.01 7.36-7.43
PvCO
2
 (mm/Hg)
XS 47.2±1.06*,c 52.6±1.6*,bc 55.8±1.74*,b 59.2±1.24* ,ab 63.4±1.99*,a 38-48
XI 36.9±1.44** 38.2±1.33** 32.9±0.95** 29.6±4.60** 33.3±2.19** 38-48
DS 45.4±0.92*,c 52.8±3.15*,bc 59.4±3.77*,abc 64.5±5.43*,ab 70.2±5.89*,a 38-48
DI 36±0.45**,ab 38.6±1.87**,a 36.4±0.88**,ab 33.8±1.30**,ab 32.8±1.52**,b 38-48
PvO
2 
(mm/Hg)
XS 30.6±1.32 42.8±2.92 48.8±8.5 52.6±7.28 48.2±8.16 37-56
XI 29.6±1.09c 37.5±1.72bc 42.4±1.79ab 43.9±3.21ab 48.7±2.3a 37-56
DS 31.2±2.03bc 28.8±1.35c 42.8±1.80ab 47.5±4.17a 55.2±6.2a 37-56
DI 33.5±3.19ab 29.2±1.56b 33.1±0.90ab 34.3±1.56ab 31.6±2.0b 37-56
tCO
2
XS 32.9±0.73* 33.8±1.37 34.1±1.49*,** 35.9±1.04 37.3±0.95* 24-32
XI 27.2±0.83* 26.5±1.20 25.1±1.10* 21.1±4.31 26.6±0.77** 24-32
DS 33.4±0.73**b 33.2±1.16b 34.1±1.08*,**,ab 35.9±1.28ab 39.2±2*,a 24-32
DI 25.9±0.59* 26±1.48 25.4±0.83 24.8±0.54 25.1±1.07** 24-32
Hb (g/dL)
XS 14.6±0.30 13.22±1.03 12.56±1.02 11.66±0.94 11.8±0.83 11-19
XI 15.5±0.55a 12.3±0.51b 11.5±0.41b 11±0.46b 10.7±0.2b 11-19
DS 15.3±0.27 15.4±0.51 15.3±0.54 14.4±0.70 13.4±0.39 11-19
DI 13.5±1.18 15.8±0.63 16.2±0.53 15.4±0.36 14.8±0.33 11-19
Ht (%)
XS 50.22±1.60 45.16±3.42 44±3.66 39.74±3.21 40.2±2.60 35-52
XI 52.3±1.93 40.5±1.66 37.8±1.39 36.3±1.57 34.8±0.75 35-52
DS 54.8±1.87 55.94±1.88 55.3±1.71 51.4±3.05 47.6±2.30 35-52
DI 44.6±4.61 51.4±2.50 53.6±1 53.1±1.51 51.1±1.40 35-52
HCO
3
 (mm/L)
XS 31.4±0.73* 32.1±1.37 32.4±1.46*,** 34.1±1.04* 35.4±0.94* 22-29
XI 26±0.79** 25.4±1.18 24±1.08* 24.3±1.12** 25.5±0.74** 22-29
DS 32±0.70*,ab 31.6±1.07b 32.3±1**,ab 33.9±1.10*,ab 37±1.83*,b 22-29
DI 24.8±0.59** 24.8±1.43 24.3±0.83* 23.8±0.54** 24±1.04** 22-29
Na (mEq/L)
XS 136.4±0.87 136±0.54 137±1.04 136.2±1.06 135.2±0.96 136-142
XI 142.8±0.30 142±1.26 142.6±1.35 127.4±16.46 140.6±1.99 136-142
DS 138±0.83 138.6±0.87 137.2±0.96 137.7±1.25 136.5±0.47 136-142
DI 140±1.06 138±2.25 135±1.92 137±1.44 137.6±1.08 136-142
K (mEq/L)
XS 3.5±0.17 3.3±0.20 3.4±0.26 3.6±0.30 3.7±0.28 2.2-4.6
XI 2.9±0.06 2.8±0.11 2.7±0.11 26.4±23.27 2.8±0.16 2.2-4.6
DS 3.5±0.19 3.8±0.23 3.4±0.23 3.7±0.29 3.8±0.36 2.2-4.6
DI 3.2±0.07 3.5±0.09 3.4±0.05 3.4±0.05 3.5±0.08 2.2-4.6
Lactic acid (mg/dL)
XS 0.6±0.12 1.1±0.26 1±0.20 0.7±0.04 1±0.16 4-12
XI 0.6±0.25 1.1±0.30 1±0.18 08±0.05 1±0.15 4-12
DS 0.5±0.05b 1.6±0.10a 1.6±0.15a 1.5±0.20a 1.2±0.50a 4-12
DI 0.6±0.25 1.1±0.35 1±0.15 0.8±0.15 1±0.15 4-12
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Novakovski et al., 2015) have reported this dose-
dependent suppression of the cardiovascular system. 
Sevoflurane and isoflurane have been reported to 
be equally arrhythmogenic in animals (Matthews 
and Hartsfield, 2004). In this study HR, SpO
2
, BT, 
RR, SP, DP and MP values were recorded at the 
beginning of the anaesthesia and SP and MP values 
were higher than the reference ranges in all groups 
(Table 2). In this study HR, SpO
2
, BT, RR, SP, 
DP and MP values were recorded at the beginning 
and during of the anaesthesia. DP and MP values 
showed significant decreases and increases during 
anesthesia in all groups (P < 0.05). DP values were 
higher than reference range at 0th 5th and 15th min 
of anaesthesia in XI, DS and DI. The statistically 
differences were detected between groups at 0th, 
5th and 30th min of anaesthesia in DP values. 
Intra-groups evaluation of DP values, there were 
statistically differences recorded at 0th and other 
times in all groups. In XS, MP value was statistically 
different at 30th min of anaesthesia than others. 
Intra-groups evaluation of MP values, the statistically 
differences were detected between 0th, 5th, 15th and 
30th, 60th min of anaesthesia in XI, DS and DI. 
However, evaluations of ECG traces from all 
groups did not show atrioventricular blockade, 
atrial fibrillation, hypoxia-related extra systoles or 
dysrhythmias. The electrolyte parameters correlated 
well with our ECG evaluations as there were no 
significant differences detected in Na and K values. 
Taylor and Clerk (2007) reported that reduction 
of BT can occur secondary to variations in skin 
thickness and environmental temperature in 
horses. In our study, BT showed decreases during 
anaesthesia in all groups. However, the decrease was 
significantly different only in XS. 
The horse’s hematologic profile is affected 
by different factors which are nutritional, 
environmental, age, sex, performance, and genetics 
(Padalino et al., 2014). At the same time stress, 
excitement, fear and the associated catecholamine 
exchange in blood circulation, as well  as 
monitoring is required (Muir and Hubbell, 2009; 
Erol and Arıcan, 2017). Anaesthetic agents cause 
dose-dependent reductions in arterial blood 
pressure with myocardial depression and peripheral 
vasodilatation. Many investigators (Ebert et al., 
1995; Aida et al., 1996; Röding et al., 1996; Duke-
RBC; red blood count, WBC; white blood count, PH; blood PvH, PvCO
2
; venous partial carbon dioxide, PvO
2
; venous 
partial oxygen pressure, tCO
2
; total carbon dioxide, Hb; hemoglobin level, Ht; hematocrit, HCO
3
; bicarbonate, *,**; P 
˂ 0.05 between groups evaluation, a,b,c; P  ˂ 0.05 in groups evaluations. References: Kawamura 2011, Aros et al. 2017, 
http://cal.vet.upenn.edu/projects/fieldservice/Equine/EQCLPATH.htm
Values Groups 0th 60th
Reference 
ranges
TP (g/
dL)
XS 7.4±0.27 6.9±0.18 5.6-7.9
XI 7.05±0.18 a 6.2±0.10 b 5.6-7.9
DS 7.07±0.25 a 6.47±0.26 b 5.6-7.9
DI 7.4±0.25 6.9±0.20 5.6-7.9
AST
(g/dL)
XS 337.66±30.98 320.16±34.3 100-600
XI 591±213.50 345.25±160.08 100-600
DS 410.75±171.55 356.25±146.08 100-600
DI 450±52.23 345±122.05 100-600
ALT 
(IU/L)
XS 25±3.52 28±5.97 5-50
XI 28±8.71 40.75±9.97 5-50
DS 18.50±6.38 30.50±10.41 5-50
DI 25.2±7.28 42.3±6.65 5-50
ALP
(IU/L)
XS 3.2±0.20 2.86±0.12 1.9-3.2
XI 3.07±0.23 2.65±0.11 1.9-3.2
DS 3.40±0.12 a 2.87±0.08 b 1.9-3.2
DI 3.05±0.23 2.58±0.15 1.9-3.2
T-bil 
(mg/
dl)
XS 4.96±0.98 4.26±0.65 0-3.5
XI 4.15±0.21 3.40±0.44 0-3.5
DS 3.40±0.83 2.95±0.68 0-3.5
DI 4.1±0.65 3.2±0.78 0-3.5
γGT 
(U/L)
XS 15±2.8 15±2.7 0-87
XI 11.25±3.03 18.25±8.08 0-87
DS 14.75±2.46 12.50±3.17 0-87
DI 16±3.05 19±2.18 0-87
Glu
(IU/L)
XS 105.16±7.53 169.66±2.80 64-150
XI 92.25±1.49a 130.50±5.7b 64-150
DS 88±2.16a 186.75±17.01b 64-150
DI 104.2±8.57 165.6±3.33 64-150
Table 4. Biochemical evaluations of groups (Mean ± SE)
TP; total protein, AST; aspartate transaminase, ALT; 
alanine transaminase, ALP; alkaline phosphatase, T-bil; 
total bilirubin, γGT; α-glutamyl transferase, Glu; glu-
cose, a,b,c; P  ˂ 0.05 in groups evaluations. References: 
Kawamura 2011, Takasu et al., 2013, Aros et al., 2017, 
http://cal.vet.upenn.edu/projects/fieldservice/Equine/
EQCLPATH.htm
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anaesthesia. However, these conditions are not 
fully observed during anesthesia and may vary 
depending on the anaesthetic duration (Mutoh 
et al., 1997; Muir and Hubbell, 2009).  The 
decreases of anaesthetic agent doses during the 
anaesthetic period and the concurrent ECG and 
venous blood parameters evaluations support the 
literature findings (Mutoh et al., 1997; Kronen, 
2003; Padalino et al., 2014). Yamashita et al. 
(2006) emphasized that α-2 agonists and ketamine-
midazolam combinations cause to decrease PO
2
 
values but do not significantly change PCO
2
 
and cardiovascular findings. They have also 
been associated with intrapulmonary shunts and 
ventilation-perfusion mismatch. Intermittent 
positive pressure ventilation (IPPV) suppresses 
the cardiovascular functions during general 
anaesthesia in horses because the mechanical 
ventilation increases thoracic pressure and retards 
venous blood circulation (Taylor and Clerk, 2007). 
Kushiro et al. (2005) reported that cardiovascular 
functions are more suppressed than during normal 
spontaneous breathing during anesthesia in horses 
due to the increased amount of catecholamine in 
circulation. There were statistically differences 
recorded in PvCO
2
, PvO
2
, tCO
2
 and HCO
3
 values 
between and among groups. In XS and DS, PvCO
2
 
values were higher than XI and DI at 5, 15, 30 
and 60th min of anesthesia. PvO
2
, tCO
2
 and HCO
3
 
values of DI were lower than the others at same 
times. The highest values of PvCO
2
, PvO
2
, tCO
2
 
and HCO
3
 were detected in DS at 60th min of 
anesthesia. In the current study, the observed 
decreases and increases in PvCO
2
, PvO
2
, tCO
2
 
and HCO
3
 values in groups were thought to be 
due to the changes in the amount of circulating 
catecholamine and ventilation support, and varied 
hyperglycemia and hypoxia can all cause changes in 
venous blood parameters (Robinson, 2009). These 
are potential reasons for the changes of RBC, WBC, 
Hb, Ht and lactic acid at the beginning of and during 
anaesthesia in the present study.
Analysis of blood gas samples from arterial and 
venous blood give information about ventilation 
and fluid-electrolyte balance (Hartsfield et al., 
2006; Erol and Arıcan, 2017).In venous blood 
gas parameters, the significant differences were 
detected in pH, PvCO
2
, PvO
2
, tCO
2
 and HCO
3
 
values (P < 0.05). The changes in pH values were 
noted during anesthesia in all groups. Depending 
on the changes of pH values, effected in PvCO
2
, 
PvO
2
, tCO
2
 and HCO
3
- values. These changes were 
more evident in sevoflurane groups and related to 
the compensatory response to respiratory acidosis 
and metabolic alkalosis. Venous blood values (pH, 
PvCO
2
, PvO
2
, tCO
2
 and HCO
3
) are 5-10 mmHg and 
1-5 mEq/l higher than arterial values (Steffey et al., 
2005; Marcilla et al., 2012).
The α-2 agonists cause cardiac depression and 
hypoxemia. The resulting cardiac depression 
and hypoxemia decrease PO
2
 and increase PCO
2 
values. In addition, inhalation anaesthetic agents 
cause respiratory depression and increase in PCO2 
values. The level of depression depends on doses 
of inhalation agents (Kronen, 2003). Detomidine 
is 10 times more potent and produces deeper and 
longer sedation than xylazine (Yamashita et al., 
2000; Steffey et al., 2005; Padalino et al., 2014). 
The effects of sevoflurane on CNS are lower 
than isoflurane and compared to other inhalation 
anesthetics the suppression effect is greater at 
increasing doses.  Sevoflurane reduces systemic 
vascular resistance, arterial blood pressure and 
mean pulmonary ar ter ia l  pressure  dur ing 
IOP; intraocular pressure, Reference; Komáromy et al., 2006; Monk et al., 2017
Table 5. IOP evaluation of groups (Mean ± SE)
Groups 0th 5th 15th 30th 60th Reference range
IOP (mm/Hg)
XS 24±0.6 27.8±3.81 38.7±2.95 34.7±2.58 35.4±1.15 13-37
XI 32±1 34.2±0.50 34.2±1.15 33.9±0.57 34.4±0.50 13-37
                 DS 52.3±4.45 32.7±3.73 50.3±2.71 42.3±2.59 41.5±3.33 13-37
DI 34.4±2.58 25.7±1.78 20.2±0.34 21.1±0.22 20.1±0.48 13-37
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In general anaesthesia, anaerobic metabolism 
begins to produce lactate due to decreased 
perfusion in tissues and an increase in the amount 
of lactate during anaesthesia. Along with anaerobic 
metabolism Glu levels increase due to sympathetic 
stimulation and lipolysis (Edner et al., 2005). 
Steffey and Pascoe (2002) emphasized that ɑ-2 
agonists increase the serum Glu levels in a dose-
dependent manner. In XS, DS and DI the Glu values 
were greater than reference limits at the end of the 
anesthesia (Table 4). The increase of Glu values 
were significant in XI and DS. However, DS Glu 
values were higher than reference interval. The 
changes of Lac values were detected in groups 
but they were in reference limits. The measured 
Glu values in our study showed changes due to 
anaerobic metabolism during the anaesthesia. 
The IOP measurement is part of the routine eye 
examination in horses with tonometry and has 
become more widely used in recent years. The 
reference range for horses using tonometry 
is reported as 15-37 mmHg (Komáromy et al., 
2006; Monk et al., 2017). Several factors such as 
the time of day, sedation, anesthetic agents and 
head position influence the IOP (Hall et al., 2000; 
Stine et al., 2014; Arıcan et al., 2015; Monk et al., 
2017). In the present study, there were no statistical 
differences seen in IOP values at the 0th, 5th, 15th, 
30th and 60th minutes of anaesthesia between and 
within groups. The IOP values of DS were higher 
at the 0th (Control), 15th, 30th and 60th min of 
anesthesia. No statistical differences were detected 
between and within groups. These differences were 
thought to be related to the anaesthetic agents’ 
effects on the intracranial and cerebral perfusion 
pressures. On the other hand, these results suggest 
that the anaesthetic combinations used in our study 
can be used safely for eye surgeries in horses. 
CONCLUSION
In conclusion, this study shows that the anaesthetic 
combinations of sevoflurane and isoflurane with 
xylazine and detomidine provided safe and suitable 
anaesthesia in horses.   It is a comprehensive study 
on the evaluation of anaesthesia combinations 
in horses and the transfer of our experience to 
clinicians. There were statistical differences 
depending on the anesthetic agents’ doses.
The biochemical values may be different in the 
pre-anaesthetic, anaesthetic and post-anaesthetic 
periods due to differences in anaesthetic agents. It is 
important to have information about liver function 
before and after anaesthesia. The differences in 
these values because of detoxification of anaesthetic 
agents in liver balance the anaesthetic agents’ effects 
on liver (Steffey, 2009; Hubbell et al., 2011).  In the 
present study, the biochemical parameters’ levels 
changed after anaesthesia. However, the TP, AST, 
ALT and ALP values detected, although significantly 
different, were still within the reference interval 
(Table 4). T-bil values were higher at 0 and 60th 
min of anesthesia than reference range in XS. 
At the end of anaesthesia Glu values in XS, DS 
and DI were higher than in XI and the reference 
values. The use of α-2 agonists in horses cause to 
decrease in TP value and hyperglycaemia (Muir and 
Hubbell, 2009). In our study TP values decreased 
in all groups at 60th min. This condition supported 
the literature information. The changes of AST, 
ALT and ALP values between 0th and 60th min in 
all groups were thought due to detoxification of 
anaesthetic agents in liver. The significant difference 
of ALP value in DS was more evident than others. 
However, it was within reference interval. The 
higher T-bil values reason was thought to be due 
to age, sex and gender of horses. The increases of 
Glu values in all groups supported the anaesthetic 
agents’ effects on liver.
Ketamine is the most commonly used dissociative 
anaesthetic agent in horses. It has been reported 
that i t  increases renal blood flow, mucous 
secretions of the respiratory tract and the amount 
of catecholamine in circulation. The fact that 
ketamine is metabolized in the liver was reported 
in previous studies (Hall et al., 2000; Rosetti et al., 
2008; Levionnois et al., 2010; Oku et al., 2011). 
Liver function during anaesthesia depends on liver 
blood flow, metabolites of anaesthetic agents and 
other drugs. Isoflurane and sevoflurane are less 
hepatotoxic than other inhalation anaesthetics (Topal 
et al., 2003). Our study supported the literature’s 
previously reported information (Hall et al., 2000; 
Topal et al., 2003; Rosetti et al., 2008; Levionnois et 
al., 2010; Oku et al., 2011). 
http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 08/10/2019 04:23:49 |
1410                H. EROL, M. ARICAN
J HELLENIC VET MED SOC 2019, 70(1)
ΠΕΚΕ 2019, 70(1)
in hematologic, biochemical and cardiovascular 
parameters even when these values were found 
within normal physiological limits.  It  was 
determined that both inhalation anaesthetic drugs 
studied could depress the respiratory system 
due to dose-dependent effects, and similar effects 
were observed between sevoflurane and isoflurane 
anaesthesia on the respiratory and circulatory systems. 
It has been clinically determined that the choosing of 
ɑ-2 agonist and their action times are very important 
in general anaesthesia. The cardiopulmonary changes 
were more prominent in sevoflurane groups. Our 
study did not reveal any statistical differences in 
IOP measurements. However, it should be noted that 
intraocular pressures were measured with the animals 
lying down and our results do not rule out changes 
in IOP in a standing position. We concluded that 
these anaesthesia protocols are suitable for ophthalmic 
surgery.
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